Package 63323-983-53

{"route": ["INTRAVENOUS"], "spl_id": "6487ad37-921c-4994-bef4-38854cdecec9", "openfda": {"unii": ["UXA545ABTT", "M98T69Q7HP"], "rxcui": ["1659131", "1659137", "1659149"], "spl_set_id": ["1eb40c84-0cb3-4648-a39f-f4ebc4dbcb16"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (63323-983-53)  / 15 mL in 1 VIAL, SINGLE-USE (63323-983-41)", "package_ndc": "63323-983-53", "marketing_start_date": "20180518"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "63323-983_6487ad37-921c-4994-bef4-38854cdecec9", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "63323-983", "generic_name": "Piperacillin and Tazobactam", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "3 g/15mL"}, {"name": "TAZOBACTAM SODIUM", "strength": ".375 g/15mL"}], "application_number": "ANDA203719", "marketing_category": "ANDA", "marketing_start_date": "20180518", "listing_expiration_date": "20261231"}